Immune Recovery in Advanced , ARV-naïve, HIV-1-infected Individuals Taking Dolutegravir or Ritonavir-boosted Darunavir

Clinical trial NCT02337322 · UNKNOWN

Trial details

NCT number: NCT02337322
Sponsor: Juan A. Arnaiz
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Acquired Immune Deficiency Syndrome Virus

Start date: 2015-03-31
Primary completion: 2019-12-01
Enrollment: 104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.